Management of Erythema Multiforme Minor
For erythema multiforme minor involving the buttocks, face, and arms, initiate symptomatic treatment with topical corticosteroids or oral antihistamines while identifying and treating any underlying infectious trigger, particularly herpes simplex virus or Mycoplasma pneumoniae 1, 2.
Immediate Assessment and Workup
First, confirm the diagnosis clinically by identifying the characteristic raised target lesions with acral distribution (though your case shows more widespread involvement including face and buttocks). The key diagnostic features distinguishing EM minor from more serious conditions:
- Fixed lesions lasting ≥7 days (versus urticaria which resolves within 24 hours) 2
- Target lesions without widespread blistering or epidermal detachment (which would suggest Stevens-Johnson syndrome) 3, 2
- Limited or no mucosal involvement (EM minor has minimal to no mucosal disease)
Essential Investigations
Immediately obtain:
- Mycoplasma pneumoniae serology - this is critical because M. pneumoniae requires antibiotic treatment 1, 4
- HSV serology or PCR if history suggests recurrent oral/genital lesions 1, 4
- Complete medication history for the past 2 months, including over-the-counter drugs 3
- Recent vaccination history, especially in younger patients 4
Treatment Algorithm
First-Line Symptomatic Management
Topical therapy:
- High-potency topical corticosteroids applied to affected areas 5, 2
- Oral antihistamines for pruritus 5, 2
Systemic corticosteroids consideration: While controversial, systemic corticosteroids should be considered for EM minor, particularly when lesions are extensive or symptomatic 6. The evidence from a case report suggests systemic corticosteroids are beneficial 6, though this remains debated in the literature.
Etiologic Treatment
If HSV-associated:
- Treat acute HSV infection if present
- For recurrent EM (≥6 episodes/year), initiate prophylactic antiviral therapy (acyclovir or valacyclovir) 5, 2
If Mycoplasma pneumoniae-associated:
- Macrolide antibiotics (azithromycin or clarithromycin) 4
- This is the most common antibiotic indication, accounting for 7.7% of pediatric cases 4
If drug-induced:
- Immediately discontinue the suspected culprit medication 3, 5
- Document the reaction for future avoidance
Common Pitfalls to Avoid
Do not confuse with Stevens-Johnson syndrome: SJS presents with widespread purpuric macules and blisters with significant epidermal detachment, not the raised targetoid lesions of EM 3, 2
Do not miss Mycoplasma pneumoniae: This requires specific antibiotic treatment and accounts for 15.7% of pediatric EM cases 4. Failure to treat can prolong disease.
Do not overlook HSV as a trigger: HSV causes 17.9% of pediatric cases and 61% of recurrent cases 4. Missing this means missing an opportunity for prophylaxis in recurrent disease.
Expected Course and Follow-up
EM minor is typically self-limiting, resolving within 2-4 weeks with symptomatic treatment 1, 2. Long-term sequelae are rare (1.3% in pediatric series) 4.
Monitor for recurrence: If the patient develops recurrent episodes (14.3% of cases), this strongly suggests HSV as the trigger and warrants prophylactic antiviral therapy 4. For cases unresponsive to antivirals, second-line immunosuppressive agents like azathioprine may be considered 7, though this is reserved for refractory recurrent disease.
The prognosis for EM minor is excellent with appropriate supportive care and identification of triggers 1, 2.